Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

An update of consensus guidelines for warfarin reversal.

Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH)..

Med J Aust. 2013 Mar 4;198(4):198-9.

PMID:
23451962
2.

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.

Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM; Warfarin Reversal Consensus Group..

Med J Aust. 2004 Nov 1;181(9):492-7. Review. Erratum in: Med J Aust. 2005 Jan 3;182(1):48.

PMID:
15516194
3.

Pharmacologic interventions for reversing the effects of oral anticoagulants.

Kalus JS.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S12-21. doi: 10.2146/ajhp130041.

PMID:
23640528
4.

Developing a management plan for oral anticoagulant reversal.

Dager WE.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S21-31. doi: 10.2146/ajhp130042. Erratum in: Am J Health Syst Pharm. 2013 Jul 1;70(13):1098. Dosage error in article text.

PMID:
23640529
5.

[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Angelo M, Stockner I, Wiedermann CJ.

Wien Med Wochenschr. 2008;158(21-22):615-20. doi: 10.1007/s10354-008-0610-3. Review. German.

PMID:
19052707
6.

The use of vitamin K in patients on anticoagulant therapy: a practical guide.

Hanslik T, Prinseau J.

Am J Cardiovasc Drugs. 2004;4(1):43-55. Review.

PMID:
14967065
7.

A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.

Fan J, Armitstead JA, Adams AG, Davis GA.

Pharmacotherapy. 2003 Oct;23(10):1245-50.

PMID:
14594342
8.

Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF.

Thromb Haemost. 1997 Mar;77(3):477-80.

PMID:
9065997
9.

Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation.

Tran H, Collecutt M, Whitehead S, Salem HH.

Intern Med J. 2011 Apr;41(4):337-43. doi: 10.1111/j.1445-5994.2010.02237.x.

PMID:
20403070
10.

Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.

Frontera JA, Gordon E, Zach V, Jovine M, Uchino K, Hussain MS, Aledort L.

Neurocrit Care. 2014 Dec;21(3):397-406. doi: 10.1007/s12028-014-9972-0.

PMID:
24671832
11.

PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.

Bobbitt L, Merriman E, Raynes J, Henderson R, Blacklock H, Chunilal S.

Thromb Res. 2011 Dec;128(6):577-82. doi: 10.1016/j.thromres.2011.04.017. Epub 2011 May 28.

PMID:
21621251
12.

Prothrombinex-VF use in warfarin reversal and other indications.

Kruger PC, Le Viellez AS, Herrmann RP.

Med J Aust. 2012 Apr 16;196(7):462-5.

PMID:
22509878
13.

Warfarin reversal: an audit of prescribing practices at Capital and Coast District Health Board.

Jolliffe E, Flanagan P.

N Z Med J. 2014 Sep 26;127(1403):32-40.

PMID:
25290497
14.

[Hemorrhagic complications during warfarin treatment].

Gumulec J, Kessler P, Penka M, Klodová D, Králová S, Brejcha M, Wróbel M, Sumná E, Blatný J, Klaricová K, Riedlová P, Lasota Z.

Vnitr Lek. 2006 Mar;52 Suppl 1:79-91. Review. Czech.

PMID:
16637455
15.

Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.

Cabral KP, Fraser GL, Duprey J, Gibbons BA, Hayes T, Florman JE, Seder DB.

Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24.

PMID:
22835715
16.

Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.

Tsu LV, Dienes JE, Dager WE.

Ann Pharmacother. 2012 Dec;46(12):1617-26. doi: 10.1345/aph.1R497. Epub 2012 Dec 18.

PMID:
23249867
17.

Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.

Bian C, Qi X, Li L, Zhao J, Liu X.

Arch Gynecol Obstet. 2016 Jan;293(1):69-74. doi: 10.1007/s00404-015-3768-0. Epub 2015 Jun 6.

PMID:
26048261
18.

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.

Liew A, Eikelboom JW, O'Donnell M, Hart RG.

Can J Cardiol. 2013 Jul;29(7 Suppl):S34-44. doi: 10.1016/j.cjca.2013.04.013. Review.

PMID:
23790596
19.

Warfarin-induced bleeding complications - clinical presentation and therapeutic options.

Wiedermann CJ, Stockner I.

Thromb Res. 2008;122 Suppl 2:S13-8. doi: 10.1016/S0049-3848(08)70004-5. Review.

PMID:
18549907
20.

Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

World Neurosurg. 2014 Jan;81(1):110-5. doi: 10.1016/j.wneu.2012.12.002. Epub 2012 Dec 5.

PMID:
23220122

Supplemental Content

Support Center